Top Cited Articles (59 articles with 501 citations as of March 2017)
Sort by:
Wireless accelerometer configuration for monitoring Parkinson’s disease hand tremor
,APD,Vol.2 No.2, 2013
Robert LeMoyne
Timothy Mastroianni
Warren Grundfest
Citations: 54(Details)
The effects of a supervised Pilates training program on balance in Parkinson’s disease
,APD,Vol.2 No.2, 2013
Liam Johnson
David Putrino
Ian James
Julian Rodrigues
Rick Stell
Gary Thickbroom
Frank L. Mastaglia
Citations: 45(Details)
Curcumin protects against rotenone-induced neurotoxicity in cell and drosophila models of Parkinson’s disease
,APD,Vol.2 No.1, 2013
Zhaohui Liu
Tianxia Li
Dejun Yang
Wanli W. Smith
Citations: 40(Details)
Wearable and wireless accelerometer systems for monitoring Parkinson’s disease patients—A perspective review
,APD,Vol.2 No.4, 2013
Robert LeMoyne
Citations: 31(Details)
Biological sources of L-DOPA: An alternative approach
,APD,Vol.2 No.3, 2013
Sushama A. Patil
Onkar A. Apine
Shripad N. Surwase
Jyoti P. Jadhav
Citations: 29(Details)
Pragmatic language production deficits in Parkinson’s disease
,APD,Vol.2 No.1, 2013
Thomas Holtgraves
Kelly Fogle
Lindsay Marsh
Citations: 26(Details)
Virtual games and quality of life in Parkinson’s disease: A randomised controlled trial
,APD,Vol.2 No.4, 2013
Glicia Pedreira
Antonio Prazeres
Danilo Cruz
Irênio Gomes
Larissa Monteiro
Ailton Melo
Citations: 23(Details)
Aquatic physical therapy for Parkinson’s disease
,APD,Vol.2 No.4, 2013
Talita Gianello Gnoato Zotz
Eliani Arruda Souza
Vera Lúcia Israel
Ana Paula Cunha Loureiro
Citations: 21(Details)
Implementation of a Smartphone as a Wearable and Wireless Accelerometer and Gyroscope Platform for Ascertaining Deep Brain Stimulation Treatment Efficacy of Parkinson’s Disease through Machine Learning Classification
,APD,Vol.7 No.2, 2018
Robert LeMoyne
Timothy Mastroianni
Cyrus McCandless
Christopher Currivan
Donald Whiting
Nestor Tomycz
Citations: 20(Details)
Comparison of the Analgesic Activity of Antiparkinsonian Aminoadamantane Derivatives Amantadine and Hemantane
,APD,Vol.5 No.3, 2016
Elena Ivanova
Inga Kapitsa
Elena Valdman
Tatyana Voronina
Citations: 17(Details)
The Development of Treatment for Parkinson’s Disease
,APD,Vol.4 No.3, 2015
Harishankar Prasad Yadav
Yun Li
Citations: 15(Details)
Tai Chi in Parkinson’s Disease: A Preliminary Randomized, Controlled, and Rater-Blinded Study
,APD,Vol.4 No.1, 2015
Roger Kurlan
Roye Evans
Sandra Wrigley
Shannon McPartland
Rami Bustami
Ann Cotter
Citations: 13(Details)
Racial Disparities in Parkinson Disease: A Systematic Review of the Literature
,APD,Vol.5 No.4, 2016
Chantale O. Branson
Andrew Ferree
Anna D. Hohler
Marie-Helene Saint-Hilaire
Citations: 11(Details)
Should gait speed be included in the clinical evaluation of Parkinson’s disease?
,APD,Vol.1 No.1, 2012
Joe Nocera
Chris Hass
Citations: 10(Details)
The International Classification of Functioning, Disability and Health as Applied to Parkinson’s Disease: A Literature Review
,APD,Vol.5 No.2, 2016
Audrin Said Vojciechowski
Talita Gianello Gnoato Zotz
Ana Paula Cunha Loureiro
Vera Lúcia Israel
Citations: 10(Details)
Properties of the Apathy Scale (AS) for use on Parkinson’s patients
,APD,Vol.2 No.2, 2013
Marcos Serrano-Dueñas
Pablo Martínez-Martín
Tamara Merchán
Rosaura Bravo
Maite Serrano
Citations: 8(Details)
Effectiveness of Istradefylline for Fatigue and Quality of Life in Parkinson’s Disease Patients’ and of Their Caregivers’
,APD,Vol.5 No.2, 2016
Kazuo Abe
1 1
Masashi Fujita
Hiroo Yoshikawa
Citations: 6(Details)
Potential of a planarian model to study certain aspects of anti-Parkinsonism drugs
,APD,Vol.2 No.3, 2013
Robert B. Raffa
Jeff Danah
Christopher S. Tallarida
Carrie Zimmerman
Grace Gill
Steven J. Baron
Scott M. Rawls
Citations: 6(Details)
Parkinson’s Disease Treatment as Seen from a Mechanical Point of View
,APD,Vol.5 No.4, 2016
Sarah Gebai
Mohamad Hammoud
Citations: 6(Details)
A prescription for physical therapy and exercise in Parkinson’s disease
,APD,Vol.2 No.4, 2013
Marie Saint-Hilaire
Theresa Ellis
Citations: 6(Details)
Pseudoparkinsonism: A review of a common nonparkinsonian hypokinetic movement disorder
,APD,Vol.2 No.4, 2013
Roger Kurlan
Marcie L. Rabin
Citations: 5(Details)
The Effects of Exercise on People with Parkinson’s Disease—Review
,APD,Vol.6 No.1, 2017
Iva Musulin
Citations: 5(Details)
A Brief Clinical Assessment of Cognitive Deficit with Impaired Daily Living Functioning in Parkinson’s Patients with and without Dementia
,APD,Vol.5 No.2, 2016
Sadaf Naeem
Rahila Najam
Nausheen Alam
Syed Waseem Akhter
Citations: 5(Details)
Effect of Abnormal Posture on Quality of Life in Patients with Parkinson’s Disease
,APD,Vol.5 No.2, 2016
Kyohei Mikami
Makoto Shiraishi
Tsutomu Kamo
Citations: 5(Details)
Efficacy of rehabilitation program in addition to pharmacological treatment during 8 months in Parkinson patients
,APD,Vol.1 No.2, 2012
Jesús Seco Calvo
Inés Gago Fernández
Juan Azael Herrero Alonso
Javier González Gallego
Nuria Garatachea Vallejo
Citations: 4(Details)
Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah
,APD,Vol.7 No.1, 2018
Anwar Ali Jamali
Ghulam Mustafa Jamali
Bhojo Mal Tanwani
Niaz Hussain Jamali
Moti Ram Bhatia
Citations: 4(Details)
The Cardiovascular and Cerebrovascular Effects on Cognition in Persons with Parkinson’s Disease: A Systematic Review of the Literature
,APD,Vol.4 No.2, 2015
Adrianna Carey
Rebecca Julian
Katlyn Kristeller
Peter Leonard
Sara Palmer
Laura Krisa
Citations: 4(Details)
Evaluation of Clinical Utility of the Personal KinetiGraph® in the Management of Parkinson Disease
,APD,Vol.8 No.3, 2019
Fatta B. Nahab
Hamad Abu-Hussain
Lissette Moreno
Citations: 4(Details)
Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?
,APD,Vol.6 No.1, 2017
Maria Nord
Anita Kullman
Ulf Hannestad
Nil Dizdar
Citations: 4(Details)
Lack of Association between Impulse Control Disorders and REM Sleep Behavior Disorder in Patients with Parkinson’s Disease
,APD,Vol.5 No.4, 2016
Lisette Bazán-Rodríguez
Mayela Rodríguez-Violante
Amin Cervantes-Arriaga
Guillermo Parra-López
Diego Cruz-Fino
Francisco Pascasio-Astudillo
Vanessa Alatriste-Booth
1 1
Citations: 4(Details)
Planning a Patient-Centered Parkinson’s Disease Support Program: Insights from Narrative Medicine
,APD,Vol.3 No.4, 2014
Nancy Gross
Melissa Nicolas
Susan Neigher
Shannon McPartland
Melvyn Heyes
Sandra Wrigley
Roger Kurlan
Citations: 4(Details)
The Application of Palliative Care Principles in Advanced Parkinson’s Disease
,APD,Vol.5 No.4, 2016
Sunjay Sethi
Anna DePold Hohler
Citations: 4(Details)
Medical Food to Stop the Progression of Parkinson’s Disease
,APD,Vol.3 No.2, 2014
Don McCammon
Citations: 4(Details)
Aquatic Physiotherapy and Parkinson’s Disease: Effects on Functional Motor Skills
,APD,Vol.9 No.1, 2020
Bruna Yamaguchi
Manoela de Paula Ferreira
Vera Lúcia Israel
Citations: 3(Details)
Parkinson’s disease: Is there a light at the end of a tunnel?
,APD,Vol.2 No.4, 2013
Andrei Surguchov
Citations: 3(Details)
Preliminary Network Centric Therapy for Machine Learning Classification of Deep Brain Stimulation Status for the Treatment of Parkinson’s Disease with a Conformal Wearable and Wireless Inertial Sensor
,APD,Vol.8 No.4, 2019
Robert LeMoyne
Timothy Mastroianni
Donald Whiting
Nestor Tomycz
Citations: 3(Details)
Preliminary evidence of discourse improvement with dopaminergic medication
,APD,Vol.2 No.2, 2013
Janelle Sanchez
Kristie A. Spencer
Citations: 3(Details)
Differences between Istradefylline Responders and Non-Responders in Parkinson’s Disease
,APD,Vol.6 No.2, 2017
Asako Yoritaka
Nobutaka Hattori
Citations: 3(Details)
Parkinson Kinetic Graph: Are Motor Fluctuations in Parkinson Disease Related with Disease Duration?
,APD,Vol.7 No.1, 2018
Esther Berghuis
Barbera Van Harten
Mirjam Van Kesteren-Biegstraaten
Wijnand Rutgers
Nicolaas Verwey
Citations: 3(Details)
Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease
,APD,Vol.6 No.2, 2017
Maria Nord
Peter Zsigmond
Anita Kullman
Nil Dizdar
Citations: 2(Details)
Resistance Training in Parkinson’s Disease: A Longitudinal Study
,APD,Vol.6 No.2, 2017
Luca Beratto
Federico Abate Daga
Ruben Allois
Massimiliano Gollin
Citations: 2(Details)
Five-Year Outcomes of Bilateral Subthalamic Nucleus Stimulation in Japanese Patients with Parkinson’s Disease
,APD,Vol.4 No.2, 2015
Atsushi Umemura
Miwako Miyata
Yuichi Oka
Kenji Okita
Genko Oyama
Yasushi Shimo
Nobutaka Hattori
Citations: 2(Details)
Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions
,APD,Vol.6 No.1, 2017
Pamela Latino
Stefania Tagliente
Clelia Pellicano
Morena Giovannelli
Francesco E. Pontieri
1 1
Citations: 2(Details)
Factors affecting early decline of executive function after subthalamic nucleus stimulation in Parkinson’s disease
,APD,Vol.2 No.3, 2013
Atsushi Umemura
Yuichi Oka
Rika Tsuboi
Sonoko Fujii
Yoko Shimizu
Kenji Okita
Noriyuki Matsukawa
Kazuo Yamada
Citations: 2(Details)
Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo
,APD,Vol.2 No.1, 2013
Amy M. Todd
Brian E. Staveley
Citations: 2(Details)
The activity of antiparkinsonian drug hemantane in models of peripheral inflammation and lipopolysaccharide-induced neuroinflammation
,APD,Vol.2 No.1, 2013
Elena Ivanova
Inga Kapitsa
Elena Valdman
Tatyana Voronina
Citations: 2(Details)
Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline
,APD,Vol.3 No.3, 2014
Wilfried Dimpfel
Christian Oehlwein
Josef Anton Hoffmann
Thomas Müller
Citations: 2(Details)
Clinical Experience with Generic Rasagiline (Ralago®) in Patients with Parkinson’s Disease: An Open-Label, Multicenter, Observational Study
,APD,Vol.8 No.2, 2019
Dávid Pintér
Júlia Lajtos
József Janszky
Norbert Kovács
Citations: 2(Details)
Distinction of an Assortment of Deep Brain Stimulation Parameter Configurations for Treating Parkinson’s Disease Using Machine Learning with Quantification of Tremor Response through a Conformal Wearable and Wireless Inertial Sensor
,APD,Vol.9 No.3, 2020
Robert LeMoyne
Timothy Mastroianni
Donald Whiting
Nestor Tomycz
Citations: 2(Details)
On Heredity Factors of Parkinson’s Disease: A Parametric and Bayesian Analysis
,APD,Vol.7 No.3, 2018
Abolfazl Saghafi
Chris P. Tsokos
Rebecca D. Wooten
Citations: 1(Details)
The Tower of Hanoi for Evaluating Dysexecutive Syndrome in Patients with Parkinson’s: Standardization Values
,APD,Vol.6 No.3, 2017
Marcos Serrano-Dueñas
Belén Calero
Maite Serrano
Citations: 1(Details)
A Blueberry Extract Supplemented Diet Partially Restores α-Synuclein-Dependent Lifespan Loss and Developmental Defects in Drosophila
,APD,Vol.3 No.2, 2014
David B. Lipsett
Brian E. Staveley
Citations: 1(Details)
Inhibition of foxo and minibrain in Dopaminergic Neurons Can Model Aspects of Parkinson Disease in Drosophila melanogaster
,APD,Vol.5 No.1, 2016
Mahin S. Chavoshi
Brian E. Staveley
Citations: 1(Details)
Low Frequency of Leisure-Time Activities Correlates with Cognitive Decline and Apathy in Patients with Parkinson’s Disease
,APD,Vol.3 No.3, 2014
Kayoko Miura
Shutaro Takashima
Mie Matsui
Kortaro Tanaka
Citations: 1(Details)
Sleep Disturbance in Parkinson’s Disease Varies with Age of Onset and Family History
,APD,Vol.5 No.4, 2016
Divya Madhusudhan
Daniella Sisniega
Andrew Ferree
Janice Weinberg
Marie Saint-Hilaire
Samuel Ellias
Anna DePold Hohler
Citations: 1(Details)
Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients
,APD,Vol.1 No.1, 2012
Rui Zhang
Danielle C. Spengler
Marie-Helene Saint-Hilaire
Anna D. Hohler
Citations: 1(Details)
Comparison of continuous versus pulsatile dopaminergic therapy in the erderly with Parkinson’s Disease
,APD,Vol.2 No.2, 2013
Fulvio Lauretani
Gian Paolo Ceda
Augusto Scaglioni
Anna Nardelli
Citations: 1(Details)
LDN-73794 Attenuated LRRK2-Induced Degeneration in a Drosophila Parkinson’s Disease Model
,APD,Vol.4 No.3, 2015
Dejun Yang
1 1
1 1
Sharmila Das
Loujing Song
Tianxia Li
Jianqun Yan
Wanli W. Smith
Citations: 1(Details)
Effects of Cholinesterase Inhibitors in Cognition on Parkinson’s Disease Dementia: A Systematic Review and Meta-Analysis
,APD,Vol.4 No.4, 2015
Marina Martorelli
Larissa Monteiro
Ailton Melo
Citations: 1(Details)